Traditional herbal formulations, such as Juzen-taiho-to , are used extensively in medical practice in Asia even though their mechanism of action remains elusive. This study tested a hypothesis that TJ-48 is protective against hepatocarcinogenesis by impeding Kupffer cell-induced oxidative stress. Forty-eight patients were randomly assigned to receive TJ-48 (n 5 10), or no supplementation (n 5 38) for up to 6 years after surgical treatment for hepatocellular carcinoma (HCC). In addition, to investigate the mechanism of protective action of TJ-48, diethylnitrosamine-containing water was administered for 22 weeks to male mice that were fed regular chow or TJ-48-containing diet. Liver tumor incidence, cell proliferation, number of 8-hydroxy-2 0 -deoxyguanosineor F4/80-positive cells, and cytokine expression were evaluated. Although most of the patients experienced recurrence of HCC, a significantly longer intrahepatic recurrence-free survival was observed in the TJ-48 group. In mice, TJ-48 inhibited the development of liver tumors, reduced oxidative DNA damage, inflammatory cell infiltration and cytokine expression. Administration of TJ-48 improves intrahepatic recurrence-free survival after surgical treatment of hepatocellular carcinoma. On the basis of animal experiments, we reason that the protective mechanism of TJ-48 involves inhibition of Kupffer cells. This leads to lower levels of pro-inflammatory cytokines and oxidants in liver which may slow down the process of hepatocarcinogenesis and improves hepatic recurrence-free survival in patients with HCC.
Hepatocellular carcinoma (HCC) is one of the world's most common cancers and it is commonly associated with liver cirrhosis due to alcohol and chronic viral infection (hepatitis virus B and C), aflatoxin B1 exposure, and a variety of metabolic liver diseases. 1, 2 Chronic inflammation is thought to be tightly linked to the mechanisms of HCC through increased production of free radicals from macrophages and neutrophils at the site of inflammation. 3, 4 Indeed, markers of oxidative stress, such as 8-hydroxydeoxyguanosine (8-OHdG), 4-hydroxynonenal and malondialdehyde, are commonly elevated in the liver of patients with chronic viral hepatitis infection and correlate well with the degree of viral infection and inflammation, known risk factors for HCC. [5] [6] [7] Recently, we evaluated the relationship between inflammation, intrahepatic oxidative stress, oxidative DNA damage and the progression of carcinogenesis in HCV-infected human liver and showed that patients with greater intra-hepatic oxidative stress exhibited much faster HCC recurrence. 8 Because a strong correlation exists between inflammatory cells in liver, oxidative stress and cancer, chronic inflammation is considered to be one of the prime targets for therapeutic intervention to prevent both progression of chronic liver disease into cancer, and relapse of HCC. Currently available anti-viral therapies, which are partially directed towards mitigation of intra-hepatic inflammation, are the only means of interrupting the progression from chronic hepatitis to HCC. 9 However, complementary and alternative medicines are becoming popular among patients with liver disease, particularly chronic hepatitis C and alcohol-induced liver disease. 10 Silymarin, glycyrrhizin, Chinese traditional medicine, herbal medicine 861, CH-100, TJ-9, TJ-108, and Phyllanthus amarus are the herbs or blends commonly used for hepatic disorders around the world. 11, 12 Juzen-taiho-to (TJ-48) is a traditional Japanese herbal medicine formula which is composed of 10 different herbs and the content of this preparation is tightly regulated. 13 It is used in medical practice in Japan for treatment of patients with chronic disease. Interestingly, several recent studies have shown that TJ-48 has an anti-tumor effect in animal models. [14] [15] [16] Although the active ingredient(s) of this or other traditional herbal medicines have not been determined and the mechanisms of their protective action remains obscure, some constituents of TJ-48 have been shown to possess antioxidant activities 17, 18 and act as immunomodulators. 19, 20 Although there is a growing body of evidence that herbal preparations may prove beneficial in management of chronic liver diseases, caution has been urged as only a few clinical trials have been conducted. This study, an extension of our previous observation that higher intrahepatic inflammation correlates with shorter disease-free survival after removal of the primary HCC, 8 tested if administration of TJ-48 will have a beneficial effect in patients who underwent liver tumor resection. Although relatively small, the current study shows considerable improvement in intrahepatic recurrence-free survival in patients on TJ-48 supplementation. Next, we tested a hypothesis that TJ-48 exerts its beneficial effects against liver carcinogenesis by impeding Kupffer cell-induced oxidative stress. In a mouse model of liver carcinogenesis induced by diethylnitrosamine (DEN), TJ-48 inhibited the development of liver tumors, as well as reduced the number of inflammatory cells, expression of proinflammatory cytokines, and oxidative DNA damage in liver. In cultured mouse Kupffer cells, TJ-48 significantly blunted DEN-induced production of proinflammatory cytokines and reactive oxygen species. Thus, we suggest that treatment with TJ-48 may be beneficial as a chronic adjuvant therapy in patients who undergo curative HCC removal and that it acts by blunting inflammation in liver.
Material and methods

Patients and study design
This is a retrospective single-center, open-label study. From 2000 to 2005, consecutive patients in the University of Yamanashi Hospital (Yamanashi Prefecture, Japan) who (i) were diagnosed as having HCC with no vascular invasion and (ii) underwent curative surgery (resection or intra-operative microwave coagulation therapy (MCT)), were enrolled in this study. Confirmation of the complete removal of the tumor(s) in patients who underwent MCT was obtained by means of computed tomography. After surgery, patients were assigned to receive TJ-48 (n 5 10, 7.5 g daily oral dose starting 1 month after surgery and continuing for up to 6 years), or not (control group, n 5 38). TJ-48, supplied by Tsumura (Tokyo, Japan), is a mixture of 10 plants (Table I ). The mixture (28.5 g) was added to 285 ml of water, extracted at 100°C for 1 hr, filtered and spray-dried (TJ-48, 2.3 g). No adverse effects because of the administration of TJ-48 were observed. All patients returned to the ambulatory care clinic for additional tests monthly. Serum a-fetoprotein levels were measured every month. In addition, ultrasonography and computed tomography of the liver were performed every 3 and 6 months, respectively. Informed consent was obtained from each patient included in the study and the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the Institutional Board on Ethics for Human Science at the University of Yamanashi. All clinical data are summarized in Table II .
Animals and treatments
Male mice (C57BL/6N and C3H/HeN) (8 weeks old) were obtained from Charles River (Yokohama, Japan). All animals used for this study were housed in sterilized cages in a facility with a 12-hr night/day cycle. Temperature and relative humidity were held at (23 6 2)°C and (50 6 10)%, respectively. The University of Yamanashi staff maintained these animal facilities, and veterinarians were always available to ensure animal health. All animals were given humane care in compliance with governmental regulations and institutional guidelines and studies were performed according to protocols approved by the appropriate institutional review board. Before experimenting, animals were randomly assigned into one of 3 groups (Fig. 1) . Control group received tap water and a standard lab chow (Oriental Yeast, Tokyo, Japan) ad libitum throughout the study (up to 22 weeks). DEN group was given DEN (Sigma, St. Louis, MO, 25 mg/l)-containing water for 10 weeks followed by normal tap water for 12 weeks and was maintained on a standard lab chow ad libitum. DEN1TJ-48 group was similar to the DEN group except that mice were maintained on a lab chow supplemented with TJ-48 (1.6% w/w). All animals had free access to food and water and the health status of the animals was monitored every other day. Before killing, mice were anesthetized with diethyl ether and following exsanguination livers were removed, weighed and examined for presence of tumors. Sections from the right median and left lateral lobe were fixed in 10% formalin. The remaining tissue was snap frozen in liquid nitrogen. The samples were stored at 280°C until assayed.
Immunohistochemical detection of 8-hydroxy-2-deoxyguanosine (8-OHdG), proliferating cell nuclear antigen (PCNA) and F4/80 antigen Formalin-fixed, paraffin-embedded sections (5 lm) of mouse liver were mounted on glass slides and stained immunohistochemically (overnight at 4°C) with anti-8-OH-dG (1:200, Fitzgerald, Concord, MA), anti-PCNA (1:250, Abcam, Cambridge, MA), or anti-F4/80 (1:100, Serotec, Oxford, England) antibodies. Before addition of the primary antibody, sections were deparaffinized and placed in phosphate-buffered saline with 1% Tween 20. Biotinylated secondary antibody conjugated with avidin-biotin-horseradish peroxidase (DAKO Envison system HRP, DAKO Cytomation, Carpinteria, CA) and 3 0 ,3 0 -diaminobenzidine tetrahydrochloride were used for standard avidin-biotinylated peroxidase detection (8-OH-dG and PCNA). ABC Elite kit (Vector Laboratories, Statistical analysis was performed by m 3 n chi square test.
Burlingame, CA) was used as the means of secondary detection of F4/80-positive cells. All slides were counterstained with hematoxylin. To ensure the quantitative measurement of each immunoreaction, all sections from each animal and group to be compared were processed in parallel. Cells that stained positive for each primary antibody were counted in at least 10 different random fields at 3200 magnification (at least 1,000 cells in each slide) using BIOQUANT software (BIOQUANT Image Analysis, Nashville, TN) and the percentage of positive cells was calculated.
RNA isolation and real-time PCR
Although frozen, 30 mg of tissue was removed for each mouse liver sample and homogenized in 600 ll RLT buffer (Qiagen, Valencia, CA) containing 1% b-mercaptoethanol. The lysate was centrifuged for 3 min at 13,000 rpm. RNA was isolated using an RNeasy kit (Qiagen) as per the manufacturer's protocol. RNA integrity and quantification were assessed using RNA 6000 Nano Assay LabChips (Agilent Technologies, Santa Clara, CA) and analyzed on a 2100 Bioanalyzer (Agilent Technologies) as per the manufacturer's protocol. Total RNA (10 lg) was reverse transcribed using random primers and the high capacity cDNA archive kit (Applied Biosystems, Foster City, CA) according to the manufacturer's protocol. The resulting cDNA was stored at 220°C. The following Taqman (Applied Biosystems) gene expression assays were used for quantitative real-time PCR: Tnfa (Mm00443258_ml), IL-1b (Mm00434228_m1), and Gus-b (Mm00446953_m1). Reactions were performed in a 96-well assay format. Each plate contained one experimental gene and a housekeeping (Gus-b) gene. Each reaction contained 2 ll of cDNA template, 20.5 ll of RNase-free H 2 O, 2.5 ll of TaqMan gene expression assay primer and 25 ll of TaqMan universal PCR master mix (Applied Biosystems). Reactions were processed for 1 cycle of 2 min at 50°C and 10 min at 95°C, followed by 40 cycles of 15 sec at 95°C and 1 min at 60°C on the Mx3000P QPCR instrument (Stratagene, La Jolla, CA). All reactions were carried out in triplicate. The cycle threshold (C t ) for each sample was determined from the linear region of the amplification plot. The DC t value for Tnfa and IL-1b relative to the control gene Gus-b was determined. The DDC t values were calculated using treated group means relative to control group means. Fold change data were calculated from the DDC t values.
Kupffer cell isolation and assessment of cytokine production
Two experiments were conducted to evaluate the effects of TJ-48 on the production of inflammatory cytokines by Kupffer cells in vivo and in vitro. In the first experiment, 8-week-old male C57BL/6N mice were randomly divided into control (normal chow, tap water), DEN (normal chow, 25 mg/l in drinking water), and DEN (25 mg/l in drinking water)1TJ-48 (1.6% w/w in the diet) groups as detailed earlier. Kupffer cells were isolated after 5 weeks of treatment ( Fig. 1 5 U/l penicillin G; pH 7.4) and centrifuged over 16% (wt/vol) Nycodenz (Axis-Shields, Oslo, Norway) gradient for 20 min at 1,900g at 4°C. Kupffer cells were collected from under the interface, washed with GBSS-B and resuspended at a concentration of 1 3 10 6 cells/ml in D-MEM media (Invitrogen, Carlsbad, CA). Isolated Kupffer cells were seeded (10 6 per well) in 24-well dishes and cultured in D-MEM media for 12 hr. After changing the media to remove the nonadherent cells, cultures were maintained for additional 24 hr and the media was collected and stored at 280°C.
In the second experiment, 8-week-old male C57BL/6N mice were maintained on a standard lab chow and received either tap water, or DEN (25 mg/l) in drinking water for 5 weeks and Kupffer cells were isolated as detailed earlier, seeded into 24-well dishes (5 3 10 5 /well), and cultured for the first 12 hr as detailed earlier. Then, cells were cultured in D-MEM containing TJ-48 (0-1,000 lg/ml) for 24 hr. After changing the media to remove the TJ-48, cells were cultured for additional 24 hr and the media was collected and stored at 280°C.
Viability of the cells was confirmed by trypan blue exclusion and was >80% in all experiments. Purity of Kupffer cell isolates was confirmed by phagocytosis of 1 lm FITC-labeled latex beads (Polysciences, Warrington, PA) as detailed elsewhere 22 and was >90% in all experiments. Five to twenty million Kupffer cells were obtained from each mouse. In vivo treatment with DEN had no effect on either yield or viability of Kupffer cells (data not shown). Tumor necrosis factor (TNF)-a, interleukins (IL)-1b and IL-6 production from Kupffer cells into the medium were assayed using enzyme-linked immunosorbent assay kits according to the manufacturer's protocol (Biosource, Camarillo, CA). In all experiments Kupffer cells were isolated from 3 different mice in each group.
Assessment of oxidant production by Kupffer cells
Two experiments were conducted to assess the effects of TJ-48 on production of oxidants by Kupffer cells in vivo and in vitro. In the first experiment, 8-week-old male C57BL/6N mice were randomly divided into control (normal chow) and TJ-48 (1.6% w/w) groups. The mice of both groups received tap water and after 5 weeks of treatment, Kupffer cells were isolated as detailed above and seeded into 96-well tissue culture plates at the density of 2 3 10 5 cells/well. Cells were incubated in D-MEM media for 24 hr, washed with warm HBSS, and 2 0 ,7 0 -dichlorofluorescein diacetate (DCF-DA, 50 lM, Sigma) was added into each well. The plate was covered and incubated for 30 min at 37°C in the dark. Then, cells were washed with fresh HBSS and D-MEM media (control), or media with DEN (2.5 mg/ml) was added and cells incubated for additional 24 hs. In the second experiment, Kupffer cells were isolated (as detailed above) from untreated C57BL/6N mice and seeded into 96-well tissue culture plates at the density of 2 3 10 5 cells/well. Cells were incubated in D-MEM media for 12 hr, washed and fresh D-MEM media (control), or media with TJ-48 (1,000 lg/ml) were added and cells incubated for 24 hr. After loading cells with DCF-DA as detailed above, fresh D-MEM media, or with media with DEN (2.5 mg/ml) was added and cells were incubated for additional 24 hr. Oxidant production was assessed from fluorescence (485 nm excitation and 535 nm emission) of oxidized DCF-DA as previously described 23 using a microplate spectrofluorometer (SpectraMax GEMINI EM, Molecular Devices, Sunnyvale, CA).
Statistical analysis
The JMP software (ver. 6.0, SAS institute, Cary, NC) was used for statistical analysis. Intrahepatic recurrence-free survival curves were calculated using Kaplan-Meier method and were compared by means of the log-rank test. Cox proportional hazard model was used for univariate and multivariate analysis. One-way ANOVA with Newman-Keul's post-hoc test was used for the determination of significance as appropriate. A p value less than 0.05 was selected before the study as the level of significance.
Results
TJ-48 improves intrahepatic recurrence-free survival after removal of the primary HCC
In this study, a total of 48 consecutive patients were enrolled and randomly assigned to the TJ-48 group (n 5 10), or the control group (n 5 38). Patients were followed up for up to 6 years after surgical treatment of primary HCC by monthly ambulatory screening for recurrence of HCC. Baseline clinical characteristics of patients in each group are provided in Table II . There were no significant differences between groups in all parameters traditionally evaluated in patients with HCC with the exception of indocyanine green retention which was significantly greater in the TJ-48 group as compared with the controls. In the univariate analysis (Cox proportional hazard model, Table III ) of intrahepatic recurrence-free survival of the patients in this study, tumor stage was found to be a significant variable associated with poor prognosis, whereas the treatment with TJ-48 was a variable associated with significantly improved clinical outcome. No other clinical measurement collected in this study achieved statistical significance in predicting the length of intrahepatic recurrence-free survival in all 48 patients. When multivariate analysis was performed using variables that had a p value of less than 0.2 in the univariate analysis (gender, tumor multiplicity, tumor stage, evidence of liver cirrhosis and TJ-48 treatment), TJ-48 administration was identified as the only independent factor associated with improved intrahepatic recurrence-free survival after the surgery in patients with primary HCC (Table III) .
It should be noted that control and TJ-48 groups in our human population are not completely balanced with respect to the tumor diameter even though this difference was not statistically significant. Nonetheless, to address the issue of potential bias in patient distribution with respect to tumor diameter and to test whether this FIGURE 2 -Administration of TJ-48 to patients who underwent surgical treatment of hepatocellular carcinoma (HCC) improves the length of intrahepatic recurrence-free survival. Kaplan-Meier method was used to plot hepatic recurrence-free survival in a total of 48 consecutive patients who were randomly assigned to receive TJ-48 (7.5 g daily, n 5 10, solid line), or no treatment (n 5 38, dashed line). Asterisk (*) denotes statistical significant (p <0.05, Log-rank test) difference between groups. may have affected the findings on the protective action of TJ-48, we conducted additional statistical analyses. First, we determined if there is statistically significant interaction between administration of TJ-48 and tumor diameter in the Cox proportional hazard model. There was no significant difference between TJ-48 risk ratio in patients with tumors >20 mm and that in patients with tumors 20 mm. Second, TJ-48 was still significant in the Cox proportional hazard model when adjusted for tumor diameter.
TJ-48 abrogates DEN-induced hepatocarcinogenesis in the mouse
To test the mechanism of protective action of TJ-48, we used a mouse model of hepatocarcinogenesis caused by DEN. 24 We chose two mouse inbred strains for these experiments, C57BL/6N and C3H/HeN, because the former is known to be resistant to spontaneous hepatocarcinogenesis, whereas the latter is prone to liver tumors. 25 Mice were given DEN (25 mg/l) in drinking water for 10 and 22 weeks (Fig. 1) . No liver tumors were observed in mice after 10 weeks of treatment of DEN in either strain. After 22 weeks of DEN administration, 22% of C57BL/6N and 63% of C3H/HeN mice developed hepatocellular carcinomas (Table IV) . Interestingly, when mice were coadministered TJ-48 in the feed (1.6% w/w), the DEN-associated hepatocarcinogenesis was abolished completely in C57BL/6N strain, whereas tumor incidence was reduced to 41% in C3H/HeN mice.
TJ-48 blocks DEN-induced inflammation and oxidative stress in mouse liver
Even though DEN is a well-established DNA-damaging agent, the mechanisms of DEN-induced carcinogenesis also are known to involve hepatocyte death, inflammation, oxidative stress, and increased cell proliferation. 26 Therefore, we evaluated the effects of TJ-48 on cell proliferation, infiltration of the inflammatory cells, and oxidative DNA damage caused by DEN. In both mouse strains, treatment with DEN for 10 weeks resulted in increased cell proliferation in liver (as measured by the number of PCNA-positive cells, Table IV), the outcome that was not affected by TJ-48.
Treatment with DEN for 10 weeks led to a considerable increase in inflammatory cell (staining positive for F4/80 antigen 27 ) infiltration into liver in both strains of mice (Fig. 3) . However, when TJ-48 was administered concurrently with DEN, the number of F4/80-positive cells diminished dramatically. Expression of proinflammatory cytokines was evaluated by quantitative real-time PCR. In C57BL/6N mice, treatment with DEN for 10 weeks resulted in a significant increase in expression of Tnfa and IL-1b (Fig. 4) , the effects that were abrogated by TJ-48. In C3H/HeN mice, expression of IL-1b, but not Tnfa, was increased by DEN and TJ-48 was also protective.
To further characterize the effects of DEN and TJ-48 on liver inflammatory cells, C57BL/6N mice were administered DEN, or DEN1TJ-48 for 5 weeks and Kupffer cells were isolated and cultured. Protein levels for Tnfa, IL-1b and IL-6 were evaluated in the conditioned media from cultured cells. Kupffer cells isolated from mice treated with DEN were producing more proinflammatory cytokines than cells from na€ ıve mice, or mice treated with DEN1TJ-48 (Figs. 5a-5c) .
Finally, immunohistochemical staining of liver sections for 8-OH-dG showed a significant increase in oxidative DNA damage after 10 and 22 weeks of DEN treatment in C57BL/6N mice, and after 10 weeks in C3H/HeN mice (Table IV) . TJ-48 abrogated this effect of DEN significantly in the same groups. Although the overall trend in this endpoint was similar in C3H/HeN mice treated for 22 weeks, the data were not significantly different between groups.
To further evaluate whether TJ-48 has an effect on Kupffer cell-derived oxidants, C57BL/6N mice were fed a TJ-48-supplemented diet for 5 weeks; Kupffer cells isolated and cultured in presence of DEN. Addition of DEN to Kupffer cells isolated from na€ ıve mice led to a significant increase in oxidant production as measured by the oxidation of DCF-DA (Fig. 6a) . However, DEN had no effect on oxidant production by the Kupffer cells isolated from TJ-48-treated mice.
TJ-48 blocks DEN-induced activation of the Kupffer cells in vitro
To determine if TJ-48 acts directly on the Kupffer cells to prevent production of pro-inflammatory cytokines and oxidants, we isolated Kupffer cells from C57BL/6N mice treated with DEN in vivo for 5 weeks and cultured them in presence of various concentrations of TJ-48. Production of TNFa, IL-1b and IL-6 was evaluated by measuring protein levels for these cytokines in the media (Figs. 5d-5f ). As expected (see Figs. 5a-5c ), Kupffer cells isolated from DEN-treated mice produced significantly more cytokines than the cells isolated from na€ ıve mice. Interestingly, addition of TJ-48 to the cell culture media lowered the production of cytokines significantly in a dose-responsive manner. To evaluate the effects of TJ-48 on the DEN-induced oxidant production in vitro, Kupffer cells were isolated from na€ ıve mice, and cultured with or without TJ-48. Addition of DEN to cell cultures led to an increase in production of oxidants in cells cultured without TJ-48 (Fig. 6b) , but no effect was observed in cells cultured with TJ-48.
Discussion
Tumor resection is the choice of treatment for HCC; however, 5-year tumor recurrence rate exceeds 70% [28] [29] [30] and improved therapies are badly needed to address low intrahepatic recurrence-free survival. Reappearance of HCC is thought to occur due to de novo formation of tumors or intrahepatic metastasis. 31 It is likely that the same predisposition factors as those that lead to the formation of a primary tumor are causal in recurrence of most of HCC cases.
Oxidant-induced DNA damage has been strongly implicated as one of the primary causes of human cancers that are a result of chronic inflammation. 3 Chronic hepatitis virus C infection results in a vicious cycle of inflammation, necrosis, and liver regeneration which are associated with infiltration of immune cells that are major producers of reactive oxygen and nitrogen species. 32 It has been also suggested that HCV core protein may contribute to hepatic oxidative stress through mitochondrial dysfunction. 33, 34 Indeed, strong correlation between high intrahepatic inflammation and oxidative stress, and abysmal disease-free survival was observed in patients who underwent HCC removal 8 which strongly suggests that inflammatory cells in liver may be a key source for reactive intermediates that exacerbate liver injury and lead to cancer recurrence.
Combating the causes that are thought to promote carcinogenesis, such as oxidative stress, may prove to be a powerful therapeutic strategy that will improve quality of life for HCC patients by extending the disease-free survival. Although antioxidants may or may not prove to be useful as treatment of cancers, 35, 36 traditional oriental herb preparations have been shown to be beneficial in a variety of diseases through mechanisms that may include antiinflammatory and other effects. 13 In the present study, we show that administration of TJ-48, one of the commonly used herbal mixtures, improves the rate of intrahepatic recurrence of HCC after curative surgery. The median recurrence-free survival of patients receiving TJ-48 was 49 months, as compared to only 24 for the control group. Multivariate analysis showed that TJ-48 was the only independent factor associated with favorable recurrence outcome in the HCC patients. To our knowledge, this is the first report which analyzed the effect of TJ-48 on HCC recurrence after curative resection or MCT.
However, the clinical observation does not, by itself, provide sufficient clues as to what is a potential mechanism of protective action of TJ-48. Thus, in order to clarify how TJ-48 may stall tumorigenesis, we used a mouse model of hepatocarcinogenesis caused by DEN which is regarded to be similar to human HCC both histologicaly and mechanistically. 37 On the basis of the data provided by our investigations in the mouse, we argue that Kupffer cells, not hepatocytes, play important role in the mechanisms of protective action by TJ-48. Kupffer cell-derived inflammatory response, which involves both production of mitogenic cytokines and oxidants, plays a seminal role in DEN-induced hepatocarcinogenesis, 26, 38, 39 likely via activation of Kupffer cells by mediators released from necrotic hepatocytes. 40 In this study, Kupffer cells did not produce proinflammatory cytokines when treated with DEN in vitro (data not shown) even though DEN caused activation of production of reactive oxygen species by these cells both in vivo and in vitro. Although Maeda et al. 26 have shown recently that activation of NF-jB in Kupffer cells may be a result of DEN-produced hepatocyte death, our data suggest that DEN may also have a direct effect on Kupffer cells to increase production of oxidants that, in turn, may lead to activation of NF-jB. 41 DEN-induced hepatocarcinogenesis was reduced by TJ-9 (Shosaiko-to), another Japanese herbal medicine, presumably through its effect on blocking the production of oxidants and the oxidative DNA damage. 42 However, our study suggests that the mechanism of protective action of TJ-48, a similar herbal mixture, involves inhibition of Kupffer cells activation in both humans and mice, which lowers the production of pro-inflammatory cytokines and oxidants in liver, and thereby slowing the process of hepatocarcinogenesis. Our mouse experiment data suggest that Kupffer cells are the target for TJ-48 because it reduced the number of 8-OHdG-positive hepatocytes and F4/80-positive non-parenchymal cells, as well as diminished the expression of pro-inflammatory cytokines in liver. In addition, DEN-induced production of proinflammatory cytokines and reactive oxygen species by isolated Kupffer cells was blunted significantly by TJ-48 both in vivo and in vitro. TJ-48 is composed of 10 herbs and its individual ingredients have been reported to have antioxidant properties 18, 43, 44 ; hence, it is presumable that antioxidant effect is important for TJ-48 to reduce liver carcinogenesis.
Several studies have suggested that anti-tumor effect of TJ-48 may be attributable to the activation of the immune system which facilitates the clearance of tumor cells from the liver. 13, 16, 19 Specifically, natural killer (NK)T cells are known to exert prominent anti-tumor activity in the liver 45 and it has been shown that TJ-48 activates NKT cells. 46 Conversely, our results show that Kupffer cells, an important part of the innate immune response in liver, are affected in a protective way and TJ-48 causes attenuation of the production of proinflammatory cytokines. Thus, it is plausible that the effect of TJ-48 may be 2-fold-(i) promoting the phagocytosis of transformed cells and cell debris by NKT cells, (ii) preventing production of excessive amounts of oxidants and proinflammatory cytokines by Kupffer cells, which may facilitate secondary tumorigenesis. It is likely that both the factors play a role in protective mechanisms of TJ-48 in patients with HCC who underwent curative tumor resection or MCT and we suggest that modulation of immune system with TJ-48 may be a reasonable strategy as anticancer therapy given its lack of side effects and ease of use as compared with chemotherapy or interferon therapy. However, additional human studies are necessary to further evaluate the effectiveness of TJ-48 therapy in postoperative treatment of patients with HCC, as well as its potential benefit in combination with other established treatments.
Conclusion
This study presents new important information on the anti-cancer effect of TJ-48 in humans and provides mechanistic evidence that the protective effects are, at least in part, due to reduction in oxidant and cytokine production by Kupffer cells. In view of the fact that oxidative stress in the liver infected with HCV is associated with shortened intrahepatic recurrence-free survival of patients with HCC after primary tumor removal, combating oxidative stress and intrahepatic inflammation with TJ-48, or other remedies that are well-tolerated and easy to use, may prove to be beneficial in management of postoperative patients and improve their quality of life.
